Ładuje się......
Phosphodiesterase 5 inhibitors for pulmonary hypertension
BACKGROUND: Pulmonary hypertension (PH) comprises a group of complex and heterogenous conditions, characterised by elevated pulmonary artery pressure, and which left untreated leads to right‐heart failure and death. PH includes World Health Organisation (WHO) Group 1 pulmonary arterial hypertension...
Zapisane w:
| Wydane w: | Cochrane Database Syst Rev |
|---|---|
| Główni autorzy: | , , , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
John Wiley & Sons, Ltd
2019
|
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6354064/ https://ncbi.nlm.nih.gov/pubmed/30701543 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD012621.pub2 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|